Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 2
1977 1
1978 3
1979 3
1980 3
1982 3
1983 4
1984 7
1985 5
1986 6
1987 5
1988 5
1989 6
1990 12
1991 8
1992 7
1993 13
1994 15
1995 13
1996 17
1997 16
1998 17
1999 26
2000 51
2001 33
2002 51
2003 61
2004 62
2005 71
2006 83
2007 63
2008 66
2009 81
2010 82
2011 106
2012 89
2013 61
2014 70
2015 76
2016 79
2017 88
2018 78
2019 80
2020 80
2021 81
2022 74
2023 67
2024 33

Text availability

Article attribute

Article type

Publication date

Search Results

1,756 results

Results by year

Filters applied: . Clear all
Page 1
The effect of vitamin D on bone and osteoporosis.
Lips P, van Schoor NM. Lips P, et al. Best Pract Res Clin Endocrinol Metab. 2011 Aug;25(4):585-91. doi: 10.1016/j.beem.2011.05.002. Best Pract Res Clin Endocrinol Metab. 2011. PMID: 21872800 Review.
Vitamin D status is related to bone mineral density and bone turnover. ...However, very high doses of vitamin D once per year may have adverse effects. When patients with osteoporosis are treated with a bisphosphonate, they should receive …
Vitamin D status is related to bone mineral density and bone turnover. ...However, very high doses of vitamin D …
The clinician's guide to prevention and treatment of osteoporosis.
LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, Siris ES. LeBoff MS, et al. Osteoporos Int. 2022 Oct;33(10):2049-2102. doi: 10.1007/s00198-021-05900-y. Epub 2022 Apr 28. Osteoporos Int. 2022. PMID: 35478046 Free PMC article.
The Bone Health and Osteoporosis Foundation (BHOF) - formerly the National Osteoporosis Foundation - first published the Clinician's Guide in 1999 to provide accurate information on osteoporosis prevention and treatment. ...The Clinician's Guide offers concis …
The Bone Health and Osteoporosis Foundation (BHOF) - formerly the National Osteoporosis Foundation - first published the Clini …
Osteoporosis in elderly: prevention and treatment.
Srivastava M, Deal C. Srivastava M, et al. Clin Geriatr Med. 2002 Aug;18(3):529-55. doi: 10.1016/s0749-0690(02)00022-8. Clin Geriatr Med. 2002. PMID: 12424871 Review.
Osteoporosis is a major clinical problem in older women and men. Almost any bone can fracture as a result of the increased bone fragility of osteoporosis. ...Several other modifiable and nonmodifiable risk factors for osteoporosis have also been identified. T …
Osteoporosis is a major clinical problem in older women and men. Almost any bone can fracture as a result of the increased bone fragi …
Osteoporosis: now and the future.
Rachner TD, Khosla S, Hofbauer LC. Rachner TD, et al. Lancet. 2011 Apr 9;377(9773):1276-87. doi: 10.1016/S0140-6736(10)62349-5. Epub 2011 Mar 28. Lancet. 2011. PMID: 21450337 Free PMC article. Review.
Osteoporosis is a common disease characterised by a systemic impairment of bone mass and microarchitecture that results in fragility fractures. With an ageing population, the medical and socioeconomic effect of osteoporosis, particularly postmenopausal ost …
Osteoporosis is a common disease characterised by a systemic impairment of bone mass and microarchitecture that results in fragility …
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.
Avenell A, Mak JC, O'Connell D. Avenell A, et al. Cochrane Database Syst Rev. 2014 Apr 14;2014(4):CD000227. doi: 10.1002/14651858.CD000227.pub4. Cochrane Database Syst Rev. 2014. PMID: 24729336 Free PMC article. Review.
BACKGROUND: Vitamin D and related compounds have been used to prevent osteoporotic fractures in older people. ...Supplements of vitamin D and calcium may prevent hip or any type of fracture. There was a small but significant increase in gastrointestina …
BACKGROUND: Vitamin D and related compounds have been used to prevent osteoporotic fractures in older people. ...Supplements o …
Management of Postmenopausal Osteoporosis: ACOG Clinical Practice Guideline No. 2.
ACOG Committee on Clinical Practice Guidelines–Gynecology. ACOG Committee on Clinical Practice Guidelines–Gynecology. Obstet Gynecol. 2022 Apr 1;139(4):698-717. doi: 10.1097/AOG.0000000000004730. Obstet Gynecol. 2022. PMID: 35594133
PURPOSE: To provide updated evidence-based recommendations for the treatment of postmenopausal osteoporosis. TARGET POPULATION: Postmenopausal patients with primary osteoporosis. ...RECOMMENDATIONS: This Clinical Practice Guideline includes updated rec …
PURPOSE: To provide updated evidence-based recommendations for the treatment of postmenopausal osteoporosis. TARGET POPULATION …
Calcium and vitamin D for corticosteroid-induced osteoporosis.
Homik J, Suarez-Almazor ME, Shea B, Cranney A, Wells G, Tugwell P. Homik J, et al. Cochrane Database Syst Rev. 2000;1998(2):CD000952. doi: 10.1002/14651858.CD000952. Cochrane Database Syst Rev. 2000. PMID: 10796394 Free PMC article. Review.
SELECTION CRITERIA: All randomized trials comparing calcium and vitamin D to calcium alone or placebo in patients taking systemic corticosteroids. ...REVIEWER'S CONCLUSIONS: This meta-analysis demonstrated a clinically and statistically significant prevention of bon …
SELECTION CRITERIA: All randomized trials comparing calcium and vitamin D to calcium alone or placebo in patients taking syste …
[Osteoporosis].
Biver E, Ferrari S. Biver E, et al. Rev Med Suisse. 2020 Jan 15;16(676-7):78-80. Rev Med Suisse. 2020. PMID: 31961090 French.
T-score between - 2.0 and - 1.5 DS might be the BMD target to reach before considering discontinuing anti-osteoporosis treatment. A rebound of bone remodeling can occur in some patients despite receiving zoledronate after denosumab discontinuation, and the monitorin …
T-score between - 2.0 and - 1.5 DS might be the BMD target to reach before considering discontinuing anti-osteoporosis treatment. A r …
Glucocorticoid induced osteoporosis.
Hu K, Adachi JD. Hu K, et al. Expert Rev Endocrinol Metab. 2019 Jul;14(4):259-266. doi: 10.1080/17446651.2019.1617131. Epub 2019 May 16. Expert Rev Endocrinol Metab. 2019. PMID: 31094232 Review.
INTRODUCTION: Glucocorticoid-induced osteoporosis is the most common secondary cause of osteoporosis. Despite this, many patients receiving glucocorticoids are not evaluated for their skeletal health. ...Oral bisphosphonates, with concomitant vitamin …
INTRODUCTION: Glucocorticoid-induced osteoporosis is the most common secondary cause of osteoporosis. Despite this, many patie …
Who should receive calcium and vitamin D supplementation?
Verbrugge FH, Gielen E, Milisen K, Boonen S. Verbrugge FH, et al. Age Ageing. 2012 Sep;41(5):576-80. doi: 10.1093/ageing/afs094. Epub 2012 Aug 8. Age Ageing. 2012. PMID: 22877606
Combined calcium and vitamin D supplementation is recommended in the prevention and treatment of osteoporosis. ...In order to correct age-associated secondary hyperparathyroidism and to prevent osteoporotic fractures, a daily dose of 1,000-1,200 mg calcium an …
Combined calcium and vitamin D supplementation is recommended in the prevention and treatment of osteoporosis. ...In or …
1,756 results